Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: Possibility for molecular diagnosis without lagging behind the morphological analyses

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 276-278

  Sueki, Akane ^a   Matsuda, Kazuyuki ^a   Taira, Chiaki ^a   Yamaguchi, Akemi ^b   Koeda, Hiroshi ^b   Takagi, Fumio ^b   Kobayashi, Yukihiro ^a   Sugano, Mitsutoshi ^a   Honda, Takayuki ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SEIKO EPSON CORPORATION   (Japan)

Author keywords

APL; ATRA; Droplet PCR; Droplet RT PCR; PML RARA

Indexed keywords

RNA;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DROPLET REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; HUMAN; KARYOTYPING; MALE; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; PML RARA GENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QUALITATIVE ANALYSIS; REACTION TIME; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSLOCATION, GENETIC;

EID: 84870362442     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.059     Document Type: Article

References (13)

1. Mi J. Current treatment strategy of acute promyelocytic leukemia. Front Med 2011, 5:341-347.
2. Stein E., McMahon B., Kwaan H., Altman J.K., Frankfurt O., Tallman M.S. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 2009, 22:153-163.
3. Tallman M.S., Altman J.K. How I treat acute promyelocytic leukemia. Blood 2009, 114:5126-5135.
4. Kühnl A., Grimwade D. Molecular markers in acute myeloid leukaemia. Int J Hematol 2012, 96:153-163.
5. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.
6. Avvisati G. Newly diagnosed acute promyelocytic leukemia. Mediterr J Hematol Infect Dis 2011, 3.
7. Neame P.B., Soamboonsrup P., Leber B., et al. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Am J Hematol 1997, 56:131-142.
8. Matsuda K., Yamaguchi A., Taira C., et al. A novel high-speed droplet-polymerase chain reaction can detect human influenza virus in less than 30min. Clin Chim Acta 2012, 12(413):1742-1745.
9. Matsuda K., Hidaka E., Ishida F., et al. A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5' MLL into 10p12, with concurrent 3' MLL deletion. Cancer Genet Cytogenet 2006, 171:24-30.
10. Gabert J., Beillard E., van der Velden V.H., et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer Program. Leukemia 2003, 17:2318-2357.
11. Haferlach T., Bacher U., Kern W., Schnittger S., Haferlach C. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach. Ann Hematol 2007, 86:311-327.
12. Okamoto I., Nakagawa K. Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: molecular and clinical aspects. Cancer Sci 2012, 103:1391-1396.
13. Wang R., Pan Y., Li C., et al. The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers. Clin Cancer Res 2012, 1(18):4725-4732.